Citation
82 FR 46076
Multiple canonical documents share this first-page citation.
- Joint Meeting of the Psychopharmacologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments Tuesday, October 3, 2017 82 FR 46076
- Joint Meeting of the Psychopharmacologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments Tuesday, October 3, 2017 82 FR 46076
- Abbreviated New Drug Applications for Certain Highly Purified Synthetic Peptide Drug Products That Refer to Listed Drugs of Recombinant Deoxyribonucleic Acid Origin; Draft Guidance for Industry; Availability Tuesday, October 3, 2017 82 FR 46075
- Abbreviated New Drug Applications for Certain Highly Purified Synthetic Peptide Drug Products That Refer to Listed Drugs of Recombinant Deoxyribonucleic Acid Origin; Draft Guidance for Industry; Availability Tuesday, October 3, 2017 82 FR 46075
- Federal Register Vol. 82, No.190, October 3, 2017 Tuesday, October 3, 2017 82 FR 46076